Current Status of Pharmacologic Therapies in Patient Blood Management
- 1 January 2013
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Anesthesia & Analgesia
- Vol. 116 (1), 15-34
- https://doi.org/10.1213/ane.0b013e318273f4ae
Abstract
Patient blood management(1,2) incorporates patient-centered, evidence-based medical and surgical approaches to improve patient outcomes by relying on the patient's own (autologous) blood rather than allogeneic blood. Particular attention is paid to preemptive measures such as anemia management. The emphasis on the approaches being "patient-centered" is to distinguish them from previous approaches in transfusion medicine, which have been "product-centered" and focused on blood risks, costs, and inventory concerns rather than on patient outcomes. Patient blood management(3) structures its goals by avoiding blood transfusion(4) with effective use of alternatives to allogeneic blood transfusion.(5) These alternatives include autologous blood procurement, preoperative autologous blood donation, acute normovolemic hemodilution, and intra/postoperative red blood cell (RBC) salvage and reinfusion. Reviewed here are the available pharmacologic tools for anemia and blood management: erythropoiesis-stimulating agents (ESAs), iron therapy, hemostatic agents, and potentially, artificial oxygen carriers.Keywords
This publication has 179 references indexed in Scilit:
- Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) StudyArchives of Surgery, 2012
- Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelinesBritish Journal of Anaesthesia, 2011
- Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomesBritish Journal of Cancer, 2010
- Targeting the Hepcidin-Ferroportin Axis in the Diagnosis and Treatment of AnemiasAdvances in Hematology, 2009
- Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathyInternational Journal of Emergency Medicine, 2009
- The Role of Hepcidin in Iron MetabolismActa Haematologica, 2009
- Evaluating Erythropoietin-Associated Tumor Progression Using Archival Tissues from a Phase III Clinical TrialThe International Journal of Cell Cloning, 2009
- Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot studyBritish Journal of Anaesthesia, 2009
- Venous Thromboembolism and Mortality Associated With Recombinant Erythropoietin and Darbepoetin Administration for the Treatment of Cancer-Associated AnemiaJAMA, 2008
- Application of Fibrin Glue Sealant After Hepatectomy Does Not Seem JustifiedAnnals of Surgery, 2007